Each health insurance company has different guidelines on weight loss medication coverage, and these benefits vary between the companys various health plans
The STEP program demonstrated 50% of weight lost during active treatment returned within one year of stopping, while continued users maintained reductions throughout multi-year follow-up studies
Therefore, administration of this drug causes gastrointestinal side effects such as nausea or weight loss
During the following 26 weeks of treatment (extension phase), discontinuations as a result of adverse events occurred in 2.4% of patients in the T-T group (patients treated with tesamorelin for Week 0-26 and with tesamorelin for Week 26-52) and 5.2% of patients in the T-P group (patients treated with tesamorelin for Week 0-26 and with placebo for Week 26-52)
The medication works best when paired with a healthy diet, increased physical activity, and ongoing supervision
You can connect with a doctor, nurse, or coach for free on Ros website or app